Aducanumab reduces Aβ plaques in Alzheimer's disease

Movement DisordersVolume 31, Issue 11 p. 1631-1631 Hot Topics Aducanumab reduces Aβ plaques in Alzheimer's disease David E. Vaillancourt, David E. Vaillancourt Department of Applied Physiology and Kinesiology, Department of Neurology, and Department of Biomedical Engineering, University of Florida, Gainesville, FL, USASearch for more papers by this author David E. Vaillancourt, David E. Vaillancourt Department of Applied Physiology and Kinesiology, Department of Neurology, and Department of Biomedical Engineering, University of Florida, Gainesville, FL, USASearch for more papers by this author First published: 14 October 2016 https://doi.org/10.1002/mds.26833Citations: 4 Dr. Vaillancourt has received grant support from NIH, Bachmann-Strauss Foundation, and Tyler's Hope Foundation. He is co-founder and manager of Neuroimaging Solutions. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume31, Issue11November 2016Pages 1631-1631 RelatedInformation